![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Germain Dominique P
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.11, Iss.10, 2002-10, pp. : 1467-1476
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Enzyme Replacement Therapy for Fabry Disease: A Systematic Review of Available Evidence
Drugs, Vol. 69, Iss. 16, 2009-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
-Galactosidase replacement therapy in Fabry's disease
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :